KOD Kodiak Sciences Inc

P/E --
Forward P/E --
Price/Sales --
Beta 2.035
Div Yield --
Market Cap --

Company Analysis

Latest News

🔴 Kodiak Sciences is trading 4.15% down today amid dilution concerns over $350 million stock-sale program

Kodiak Sciences is trading 4.15% down at $89.11, as investors weigh potential dilution following an October 20 stock-sale filing. - The automatic shelf filing...

🟢 Kodiak Sciences rises 4.6% — Biotech Sector Surges on M&A Activity and Positive Clinical Trial Data

With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...

🟢 Kodiak Sciences is trading 4.3% up with no clear company-specific catalyst

Kodiak Sciences is trading at $89.50, up 4.37%, with no clear company-specific catalyst identified for the October 19 move. - The supplied premarket alert...

🔴 Kodiak Sciences is trading 5.6% down in pre-market as biotech ETF XBI falls

Kodiak Sciences is trading at $80.99, down 5.55% in pre-market, with sector weakness the likeliest explanation; no company-specific catalyst has been...

🔴 Kodiak Sciences is trading 5.6% down in pre-market amid biotech ETF weakness

Kodiak Sciences is trading 5.55% down at $80.99 in pre-market; biotech-sector weakness is a possible context, not a confirmed cause. - Biotech ETF XBI is down...

🟢 Kodiak Sciences rises 4.3% — Biotech Sector Rallies on Positive Clinical Data and Regulatory News

With Biotech (XBI) up 2.2%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...

🟢 Kodiak Sciences is trading 4.8% up in pre-market; catalyst unclear

Kodiak Sciences is trading at $85.00, up +4.82%, with no identified catalyst for its October 15 pre-market rise. - No new company-specific announcement...

🔴 Kodiak Sciences is trading 10% down today amid market weakness after hotter-than-expected September CPI

Kodiak Sciences is trading at $82.31, down 10.17%, amid broad market weakness following hotter-than-expected September CPI, which raised rate concerns and...

🔴 Kodiak Sciences is trading 4.8% down

Kodiak Sciences is trading down 4.78% at $87.25 as of 10:16 a.m. ET on October 14, 2026, with no clear new company-specific announcement explaining the...

🔴 Kodiak Sciences is trading 4.6% down today amid possible biotech-sector pressure

Kodiak Sciences is trading at $94.72, down 4.57%, with biotech-sector weakness a possible contributor to the decline. - XBI fell 2.01% during the regular...

Kodiak Sciences to Reveal Phase 3 DAYBREAK Data at Ophthalmology Meeting

Kodiak Sciences to Reveal Phase 3 DAYBREAK Data at Ophthalmology Meeting

Kodiak Sciences is scheduled to present clinical data for all three of its late-stage assets at the American Academy of Ophthalmology (AAO) Annual Meeting on...

🟢 Kodiak Sciences rises 4.2% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity

With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...

🔴 Kodiak Sciences is trading 4% down

Kodiak Sciences is trading at $90.04, down -4.02%, with biotech-sector weakness a possible contributor. - No clear company-specific announcement or event on...

🔴 Kodiak Sciences is trading 5.3% down

Kodiak Sciences is trading at $89.42, down 5.3%, with no clear October 5 company-specific catalyst in available reports. - LifeSci Capital raised its target...